Flagship Pioneering Fund Vii, L.p. - Net Worth and Insider Trading

Flagship Pioneering Fund Vii, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Flagship Pioneering Fund Vii, L.p. owns 3 companies in total, including Evelo Biosciences Inc (EVLO) , Seres Therapeutics Inc (MCRB) , and Omega Therapeutics Inc (OMGA) .

Click here to see the complete history of Flagship Pioneering Fund Vii, L.p.’s form 4 insider trades.

Insider Ownership Summary of Flagship Pioneering Fund Vii, L.p.

Ticker Comapny Transaction Date Type of Owner
EVLO Evelo Biosciences Inc 2022-05-27 10 percent owner
MCRB Seres Therapeutics Inc 2022-07-05 10 percent owner
OMGA Omega Therapeutics Inc 2023-02-27 10 percent owner

Flagship Pioneering Fund Vii, L.p. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Flagship Pioneering Fund Vii, L.p. Ownership Network

Ownership Network List of Flagship Pioneering Fund Vii, L.p.

No Data

Ownership Network Relation of Flagship Pioneering Fund Vii, L.p.

Insider Network Chart

Flagship Pioneering Fund Vii, L.p. Owned Company Details

What does Evelo Biosciences Inc do?

Who are the key executives at Evelo Biosciences Inc?

Flagship Pioneering Fund Vii, L.p. is the 10 percent owner of Evelo Biosciences Inc. Other key executives at Evelo Biosciences Inc include Chief Medical Officer Duncan Mchale , Chief Financial Officer Marella Thorell , and See Remarks Mark Bodmer .

Evelo Biosciences Inc (EVLO) Insider Trades Summary

Over the past 18 months, Flagship Pioneering Fund Vii, L.p. made no insider transaction in Evelo Biosciences Inc (EVLO). Other recent insider transactions involving Evelo Biosciences Inc (EVLO) include a net sale of 13,391 shares made by Duncan Mchale , a net sale of 13,145 shares made by Mark Bodmer , and a net sale of 7,814 shares made by Marella Thorell .

In summary, during the past 3 months, insiders sold 0 shares of Evelo Biosciences Inc (EVLO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 36,860 shares of Evelo Biosciences Inc (EVLO) were sold and 5,411,255 shares were bought by its insiders, resulting in a net purchase of 5,374,395 shares.

Evelo Biosciences Inc (EVLO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Evelo Biosciences Inc Insider Transactions

No Available Data

Flagship Pioneering Fund Vii, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Flagship Pioneering Fund Vii, L.p.. You might contact Flagship Pioneering Fund Vii, L.p. via mailing address: 55 Cambridge Parkway, 8th Floor, Cambridge Ma 02142.

Discussions on Flagship Pioneering Fund Vii, L.p.

No discussions yet.